IRIS
MORONCINI, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.952
EU - Europa 2.059
AS - Asia 404
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 2
AF - Africa 1
Totale 6.428
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.943
IT - Italia 496
UA - Ucraina 405
SE - Svezia 302
IE - Irlanda 289
DE - Germania 213
TR - Turchia 160
DK - Danimarca 149
SG - Singapore 86
FI - Finlandia 80
KR - Corea 76
GB - Regno Unito 75
CN - Cina 45
IN - India 16
BE - Belgio 14
FR - Francia 11
CA - Canada 9
IL - Israele 7
EU - Europa 5
PL - Polonia 5
RO - Romania 5
AU - Australia 4
JP - Giappone 4
RS - Serbia 4
MY - Malesia 3
AL - Albania 2
CH - Svizzera 2
PT - Portogallo 2
TW - Taiwan 2
YE - Yemen 2
AT - Austria 1
BD - Bangladesh 1
BR - Brasile 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 6.428
Salva come PNG Salva come JPEG
Città #
Chandler 621
Jacksonville 426
Fairfield 334
Dublin 284
Ashburn 266
Des Moines 261
Wilmington 186
Woodbridge 155
Centro 149
Houston 142
New York 142
Boardman 134
Seattle 126
Ann Arbor 115
Lawrence 108
Princeton 108
San Mateo 92
Cambridge 80
Redmond 45
Turin 37
San Diego 35
Beijing 30
Marche 30
Washington 23
Los Angeles 20
London 19
Jesi 17
Ancona 15
Pune 14
Tolentino 14
Brussels 12
Falls Church 11
Kilburn 11
Helsinki 8
Izmir 8
Milan 7
Norwalk 7
Monte San Pietrangeli 6
Southwark 6
West Jordan 6
Ascoli Piceno 5
Jerusalem 5
Nürnberg 5
Osimo 5
Ottawa 5
Rome 5
Squinzano 5
Auburn Hills 4
Belgrade 4
Brisbane 4
Bucharest 4
Fermo 4
Genoa 4
Montelupone 4
Scuola 4
Camerino 3
Montréal 3
New Bedfont 3
Pagani 3
Pesaro 3
Petaling Jaya 3
Porto 3
Senigallia 3
Bengaluru 2
Brescia 2
Dongguan 2
Fabriano 2
Falconara Marittima 2
Florence 2
Gessate 2
Hanover 2
Hounslow 2
Leawood 2
Lisbon 2
Montefortino 2
Montelabbate 2
Monza 2
Pergola 2
Pisa 2
Sanaa 2
Shenzhen 2
Taipei 2
Tavullia 2
Tel Aviv 2
Weihai 2
Wuhan 2
Abidjan 1
Acton 1
Auckland 1
Beelitz 1
Bergamo 1
Bratislava 1
Bray 1
Brdo 1
Campagnano di Roma 1
Chengdu 1
Chicago 1
Chiswick 1
Copenhagen 1
Dallas 1
Totale 4.261
Salva come PNG Salva come JPEG
Nome #
The value of admission Troponin I to predict outcomes in suspected infections in elderly patients admitted in Internal Medicine: results from the SOFA-T collaboration, a multi-center study 116
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 115
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 114
The first outstanding 50 years of “Università Politecnica delle Marche”: Research achievements in life sciences 112
Preface 105
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 101
Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management 96
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 94
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 94
Development of the optimal touchscreen interface for patients with scleroderma 93
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 92
Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice. 89
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 88
Adalimumab modulates angiogenesis in psoriatic skin 85
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 85
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 82
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 82
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 82
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 79
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 78
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 77
Pathogenic autoantibodies in systemic sclerosis 76
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 73
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 73
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 71
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 71
MOTIF-GRAFTED HYBRID POLYPEPTIDES AND USES THEREOF 70
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine 70
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 70
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 69
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 69
Analysis of ATP8B4 F436L missense variant in a large systemic sclerosis cohort 69
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 69
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 68
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 67
Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin. 67
Delection of typical and atypical bovine spongiform encephalopathy and scraipe prion strains by prion protein motif-grafted antibodies 64
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. 63
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 63
Biologics in inflammatory immune-mediated systemic diseases 63
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 63
Detection of typical and atypical BSE and scrapie prion strains by prion protein motif-grafted antibodies. 62
Agonistic antibodies in systemic sclerosis 62
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 62
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin 62
Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. 61
Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-α Therapy 61
History and scientific production of clinica medica and clinica ematologica in ancona 61
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 60
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 60
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance 60
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 59
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 59
Update of EULAR recommendations for the treatment of systemic sclerosis 59
BIOLOGIC THERAPY IN INFLAMMATORY IMMUNOMEDIATED SYSTEMIC DISEASES: SAFETY PROFILE 59
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 58
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 58
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways 58
Putative functional pathogenic autoantibodies in systemic sclerosis 56
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 55
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 55
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 54
Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress 53
Role of viral infections in the etiopathogenesis of systemic sclerosis 52
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 52
Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof 51
Development of A Solid Phase Binding Assay For Detection of Conformational Anti-PDGFR Autoantibodies In the Serum of Patients Affected By Scleroderma 50
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 50
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 49
Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc 49
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 48
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 48
Reply 48
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 47
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 46
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 44
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 43
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 42
New insights into the role of oxidative stress in scleroderma fibrosis. 42
Letter to the Editor. Reply to Magalon J et al. (CT-1406) 42
The proinflammatory cytokine interleukin 18 regulates feeding by acting on the bed nucleus of the stria terminalis 42
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 41
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 41
Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody 40
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. 40
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 37
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 36
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 36
Monoacylglycerol lipase regulates fever response 36
STIMULATORY AUTOANTIBODIES AGAINST PDGF RECEPTOR IN A LARGE COHORT OF ITALIAN SCLERODERMA PATIENTS 35
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 35
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 35
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 34
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach 33
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 33
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 32
Current take on systemic sclerosis patients’ vaccination recommendations 32
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 31
Rituximab for the treatment of cutaneous involvement in systemic sclerosis. evidence for a pathogenetic role of B-CELLS 31
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 31
Totale 6.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 6 13
2019/2020547 8 4 94 4 87 7 95 10 90 7 27 114
2020/20211.469 67 141 176 3 185 98 177 104 162 129 152 75
2021/2022865 44 190 23 29 22 43 20 53 83 57 125 176
2022/20231.821 148 189 128 162 113 403 9 101 382 24 122 40
2023/2024972 163 38 66 138 167 233 21 51 11 82 2 0
Totale 6.606